量子之歌佈局潮玩市場,Letsvan成納斯達克上市體系下首家中國潮玩企業
量子之歌集團(NASDAQ: QSG,以下簡稱“量子之歌”)今日宣佈對深圳熠起文化有限公司(以下簡稱“Letsvan”)達成併購投資合作。此次併購交易完成後,Letsvan將正式成爲量子之歌控股子公司,其財務數據將納入量子之歌集團合併報表範圍。根據已公開信息,此次交易創下了2025年中國潮玩行業在一級市場的最高融資紀錄。此次投資不僅標誌着量子之歌正式進軍潮流玩具市場及更廣闊的消費領域,也標誌着Letsvan成爲中國首家擁有納斯達克上市公司平臺的潮流玩具企業,爲其未來在全球市場的擴張奠定了堅實基礎。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.